• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2000년도 춘계학술발표대회
• /
• pp.550-553
• /
• 2000

The polymeric matrices made with poly(D,L-lactide-co-glycolide) were prepared using copolymer of poly(D,L-lactide) and poly(ethylene glycol) for application of drug delivery systems. Catalyst made use of stannous actoate. Particle size were differ greatly$(435.3{\pm}11.2{\sim}2284.1{\pm}188.5)$ that nanoparticle made use of according to solvent of various kinds. Polymer could a sharp distinction with copolymerized among LE-1, LE-2 and LE-3 of PLA and PEG of content that to examine $^1H-NMR$ of copolymer make refine and reprecipitation. Drug delivery effect at PLGA nanoparticle : PLA amount more then proved highly drug delivery amount that each LE-1, LE-2, LE-3, drug and solvent was 40mg, 20mg and 10mg. Drug delivery effect proved higher 20mg that change(10mg, 20mg, 40mg) at drug feeding amount with LE-2. The first a lot of drug proved delivery. LE-3 most lactide content proved much delivery since biodegradable on PLGA copolymer result from lactide. Also biodegradable rate was highest at LE-3 much of lactide content, because influence at biodegradable effect of lactide by inclusive of soft PEG.

• Journal of Pharmaceutical Investigation
• /
• 제38권2호
• /
• pp.99-104
• /
• 2008

PLGA micro/nano particles encapsulating ranitidine as a hydrophilic model drug were prepared by the double-emulsion solvent evaporation method. Surface morphology investigation by scanning electron microscope (SEM) showed that the emulsification by sonication could produce nanoparticles, whereas microparticles were prepared using high speed homogenizer. Moreover, while nanohalf-shell structure instead of spherical nanoparticle could be produced by adding poloxamer into oil phase (MC) with PLGA 504H, the addition of poloxamer didn't change particle shape in case of PLGA 502H. On the other hand, microparticle with poloxamer had more surface pores than those without poloxamer. The size and polydispersity (PDI) of particles were determined by particle size analyzer. Effective diameters of particles were in the range of $400{\sim}800\;nm$ and $1200{\sim}3300\;nm$ in case of nanoparticles and microparticles, respectively. Encapsulation efficiencies were in the range of $1.2{\sim}2.9%$. The addition of poloxamer produced the particles with higher encapsulation efficiency. In vitro release study in phosphate buffer (pH 7.4) at $37^{\circ}C$ showed common large initial burst release. However, the relative slower release profile could be observed in case of microparticles. Poloxamer addition increased the release rate, which was thought to be related to the increased surface area of particles.

• 대한화학회지
• /
• 제47권5호
• /
• pp.479-486
• /
• 2003

본 연구에서는 나노입자의 제조 방법인 용매 확산 방법 (emulsification diffusion method)을 이용하여 poly (DL-lactide-co-glycolide) (PLGA) 나노입자를 제조하고 지용성 vitamin A (Retinol)와 Vitamin E acetate를 담지하였다. 고분자 용액은 물에 잘 혼합되는 유기 용매인 에탄올과 아세톤의 이종 혼합 용매를 사용하여 제조하였고 유화제는 생체적합성이 우수한 polyethyleneglycol-polypropyleneglycol diblock copolymer를 사용하였다. 고분자의 농도, 유화제의 농도, 물/오일상의 비, 고분자/약물의 비 등의 인자들이 나노입자의 형성과 약물의 담지 효율에 미치는 영향을 조사하였다. 활성 성분이 로딩된 나노입자를 제조한 후, 입자의 크기와 분포도는 광산란 입도 분석기를 이용하여 측정하였고 담지 효율은 UV-visible spectroscopy를 이용하여 평가하였다. 제조된 나노입자는 50-200 nm의 크기와 단분산 형태의 크기분포를 보였으며 담지 효율은 50-60%까지 얻을 수 있었다. 또한, 유기상과 수용액상에서 이종 혼합 용매와 고분자의 농도에 대한 적당한 조건을 조절함으로써 PLGA 나노입자의 높은 수율과 우수한 물리적 특성을 얻을 수 있었다.

• 대한화학회지
• /
• 제47권6호
• /
• pp.601-607
• /
• 2003

생분해성 고분자인 poly(DL-lactide-co-glycolide)(PLGA)를 자발적 유화용매 확산(spontaneous emulsification solvent diffusion, SESD)법을 이용하여 표면이 양이온으로 수식된 나노입자로 제조하고 그 특성을 조사하였다. 고분자 용액은 에탄올과 아세톤의 이종 혼합 용매를 사용하였고, 유화제는 양이온성 유화제인 cetyltrimethylammonium chloride(CTAC), tetradecyltrimethylammonium bromide(TTAB)와 비이온성 유화제인 polyethylene glycol-block-polypropylene glycol 공중합체(Lutrol F68)를 사용하였다. 제조한 입자에 결합한 백신은 인플루엔자($H_3N_2,\;H_1N_1$, B strain)이었고 입자에 대한 백신의 코팅 양은 NHS-fluorescein을 사용하여 확인하였다. 양이온성과 비이온성 유화제가 표면에 수식된 입자의 크기는 160-180 nm와 80-90 nm이었고 제타포텐셜은 $50{\sim}60$ mV, -10 mV이었다. 백신 코팅 후 입자의 크기는 양이온성이 380-400 nm, 비이온성은 별다른 크기 변화가 없었다. 양이온이 수식된 입자에 코팅된 백신의 양은 22.73 ${\mu}g$/mg이었다.

• IMMUNE NETWORK
• /
• 제11권3호
• /
• pp.163-168
• /
• 2011

Background: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. Methods: NPs containing a similar amount of ovalbumin (OVA) but different sizes were produced using a micromixer-based W/O/W solvent evaporation procedure, and the efficiency of the NPs to induce the cross-presentation of OVA peptides were examined in dendritic cells (DCs). Cellular uptake and biodistribution studies were performed using fluorescein isothiocyanate (FITC)-loaded NPs in mice. Results: The NPs in the range of $1.1{\sim}1.4{\mu}m$ in size were the most and almost equally efficient in inducing the cross-presentation of OVA peptides via $H-2K^b$ molecules. Cellular uptake and biodistribution studies showed that opsonization of the NPs with mouse IgG greatly increased the percentage of FITC-positive cells in the spleen and lymph nodes. The major cell type of FITC-positive cells in the spleen was macrophages, whereas that of lymph nodes was DCs. Conclusion: These results show that IgG-opsonized PLGA-NPs with a mean size of $1.1{\mu}m$ would be the choice of biodegradable carriers for the targeted-delivery of protein antigens for cross-priming in vivo.

• 공업화학
• /
• 제32권5호
• /
• pp.509-515
• /
• 2021

본 연구는 생체적합성 및 생분해성의 특성을 갖는 PLGA (poly lactic-co-glycolic acid)를 이용하여 이중(w/o/w) emlusion과 유화 용매-증발 기법을 통해 PLGA 나노입자(PNP)를 제조하였고, 이에 키토산을 전하 상호작용을 통해 키토산이 코팅된 PLGA 나노입자(CPNP)를 제조하여 입자의 안정성과 생체이용률을 극대화할 수 있는 경구 투여용 약물 전달체로 사용 가능성을 입증하고자 하였다. CPNP의 화학적 구조는 ¹H-NMR 및 FT-IR을 통해 분석하였으며, 모든 특성 피크가 나타남으로써 성공적으로 제조되었음을 확인하였다. 또한, CPNP의 입자 크기, 제타 전위 및 형태학적 이미지는 DLS와 TEM을 이용하여 각각 분석하였으며, TGA를 통해 CPNP의 열적 분해 거동을 관찰하였다. 또한, CPNP의 세포 독성은 HEK293 및 L929 세포에서 MTT assay를 수행하여 확인하였고, 모든 농도에서 70% 이상의 세포 생존율을 확인함으로써 독성이 없음을 입증하였다. 이러한 결과를 통해 본 연구에서 개발된 CPNP가 경구용 약물 전달체로써 사용 가능성이 있음을 제안한다.

• 대한의용생체공학회:의공학회지
• /
• 제39권3호
• /
• pp.140-145
• /
• 2018

Cancer is a major burden of human disease worldwide. Current chemotherapy has severe side effects because the drugs affect whole body nonspecifically. In addition, the drugs to reach cancer cells are very limited. Over the last two decades, Drug Delivery System (DDS) using nanoparticles has suggested promising results to improve current limitations. In this study, we prepared PLGA nanoparticles with different charge properties and observed their stability and internalization effect to cancer cells. Results using Dynamic Light Scattering (DLS) and Fourier Transform Infrared Spectroscopy (FTIR) confirmed the size and chemical composition of the nanoparticles. The stability of the nanoparticles in pH buffers were variable depending on charge properties. The nanoparticles showed different cytotoxicity and internalization effects to MCF-7 human breast cancer cells. In conclusion, we demonstrated the importance of delicately engineered nanoparticles for better DDS in cancer.

• 폴리머
• /
• 제27권4호
• /
• pp.370-376
• /
• 2003

나노입자의 제조 방법인 개선된 자발적 용매 확산 방법을 이용하여 폴리(DL-락타이드-co-글리콜라이드) 나노입자를 제조하였다. 고분자 용액은 물에 잘 혼합되는 유기 용매인 에탄올과 아세톤의 이종 혼합 용매를 사용하여 제조하였다. 유화제 및 안정제는 우수한 생체적합성을 갖는 PEG-PPG 블록 공중합체를 사용하였다. 최적의 나노입자 제조 조건을 얻기 위하여 나노입자 형성에 영향을 주는 인자들인 안정제의 종류 및 농도, 교반 방법, 물/오일 상의 비, 고분자의 농도 등을 고려하였다. 나노입자 제조 후, 입자의 크기 및 분산도는 광산란 입도 분석기를 이용하여 평가하였다. 제조된 나노입자는 50~200 nm의 크기와 단분산 형태의 크기분포를 보였다. 또한, 유기상과 수용액상에서 이종 혼합 용매와 고분자의 농도에 대한 적당한 조건을 조절함으로써 PLGA 나노입자의 높은 수율과 우수한 물리적 특성을 얻을 수 있었다.

• 대한치과보철학회지
• /
• 제46권6호
• /
• pp.620-627
• /
• 2008

STATEMENT OF PROBLEM: A biochemical approach for surface modification has offered an alternative for physicochemical and morphological methods to obtain desirable bone-implant interfaces. PURPOSE: The purpose of the present study was to investigate cell responses to poly (D,L-lactide-co-glycolide) (PLGA)/$1{\alpha}$,25-(OH)$_2D_3$ coating with reference to cellular proliferation and differentiation in vitro. MATERIAL AND METHODS: 96 titanium discs were fabricated and divided into four groups. Group 1 was anodized under 300 V as control. Group 2, 3 and 4 were anodized then coated with 3 ml PLGA/$1{\alpha}$,25-(OH)$_2D_3$ solutions. Amount of the solutions were 2 ul, 20 ul and 200ul respectively. The osteoblast-like Human Osteogenic Sarcoma (HOS) cells were seeded and cultured for 1, 3 and 7 days. MTSbased cell proliferation assay and ALPase activity test were carried out. RESULTS: PLGA nanoparticles were observed as fine, smooth and round and HOS cells attached to the anodized surfaces through strand-like and sheet-like filopodia. After 3 days of culture, the dendritic filopodia were exaggerated and sheet-like cytoplasmic projections covered the coated titanium surfaces. After 3 days of culture, all of the groups showed increased cellular proliferation and the lowest proliferation rate was measured on group 2. Higher amount of incorporated $1{\alpha}$,25-(OH)$_2D_3$ (Group 3 and 4) improved cellular proliferation but the differences were not significant statistically (P > .05). But they increased the rate of ALP activities than the control group at day 3 (P < .05). CONCLUSION: Biodegradable PLGA nanoparticles incorporated with vitamin D metabolite positively affected proliferation and differentiation of cells on the anodized titanium surface.

• IMMUNE NETWORK
• /
• 제13권1호
• /
• pp.30-33
• /
• 2013

Previously we showed that biodegradable nanoparticles containing poly-IC or CpG oligodeoxynucleotide (ODN) together with ovalbumin (OVA) were efficient at inducing MHC-restricted presentation of OVA peptides in dendritic cells. The CTL-inducing activities of the nanoparticles were examined in the present study. Nanoparticles containing poly-IC or CpG ODN together with OVA were prepared using biodegradable polymer poly(D,L-lactic acid-co-glycolic acid), and then were opsonized with mouse IgG. The nanoparticles were injected into the tail vein of mice, and 7 days later the OVA-specific CTL activities were measured using an in vivo CTL assay. Immunization of mice with the nanoparticles containing poly-IC or CpG ODN together with OVA elicited potent OVA-specific CTL activity compared to those containing OVA only. In accordance with these results, nanoparticles containing poly-IC or CpG ODN together with OVA exerted potent antitumor activity in mice that were subcutaneously implanted with EG7.OVA tumor cells. These results show that encapsulation of poly-IC or CpG ODN together with antigen in biodegradable nanoparticles is an effective approach for the induction of potent antigen-specific CTL responses in vivo.